Chronicle of Convergence · Daily editorial · 2026-09-11
Photo: Platinum-based chemotherapy in childhood causes mutations that age the liver
A pavilion for Richter. Livers that look like adult cells.
By Dr. Wallace Lynch · Editor in Chief · ~292 words
Qatar Museums will put a permanent pavilion for Gerhard Richter in Doha this autumn. It will stand in MIA Park, outside the Museum of Islamic Art. A building for one painter, beside the museum the city already has.
On Friday, September 11, 2026, we hold that park to one pressure: what still ages in the body when the room is a celebration, and when the industry asks if it is legal to slow down.
Platinum chemotherapy in childhood left liver cells looking like adult cells. Cisplatin. Carboplatin. The tissue aged. The long term risk of new tumors may rise. In Pennsylvania a coroner confirmed two measles deaths last month were infants. The virus itself caused one of them. Robots are learning to feel. Dexterous work is still the barrier. Touch is the data they did not have. OpenAI wants to know if an AI slowdown would even be legal. Antitrust, they worry, could block the coordination they call urgent. After an Anthropic researcher quit, warning the race is gambling with our lives. NASA is standing up a United States Space Academy, less than two weeks after the executive order. Djibouti will sign the Artemis Accords at Headquarters on the 14th, the 72nd country. Three Massachusetts utilities are suing Hydro-Quebec over hydropower that did not arrive in a winter cold snap. Hydro-Quebec is suing them back. The Rabkin Prize named eight arts journalists, $50,000 each, unrestricted. Freelands will put £100,000 a year into three UK arts organizations for five years.
A pavilion in the park. A liver that looks older than the child. A slowdown that may not be allowed. Convergence is not the building that celebrates the painter. It is whether the body is still counted when the room is already named.